Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells Post author: Post published:March 17, 2026 Post category: Continue ReadingLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer Post author: Post published:March 17, 2026 Post category: Continue ReadingPSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL Post author: Post published:March 17, 2026 Post category: Continue ReadingConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia Post author: Post published:March 1, 2026 Post category: Continue ReadingA Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies Post author: Post published:March 1, 2026 Post category: Continue ReadingAutologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release Post author: Post published:March 1, 2026 Post category: Continue ReadingExpanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein Post author: Post published:March 1, 2026 Post category: Continue ReadingStudy to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation Post author: Post published:March 1, 2026 Post category: Continue ReadingA Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Safety and Efficacy of OBX-115 in Advanced Solid Tumors Post author: Post published:March 1, 2026 Post category: Continue ReadingSafety and Efficacy of OBX-115 in Advanced Solid Tumors
GCC19CART for Patients With Metastatic Colorectal Cancer Post author: Post published:March 1, 2026 Post category: Continue ReadingGCC19CART for Patients With Metastatic Colorectal Cancer
